Stock Scorecard



Stock Summary for Dexcom Inc (DXCM) - $74.88 as of 11/20/2024 3:59:03 PM EST

Total Score

11 out of 30

Currently on the following lists
None
Tim's Recommendation
Avoid

Growth List Algorithm Criteria for DXCM

Positive earnings growth
P/E ratio less than Industry P/E Ratio
P/E ratio less than Sector P/E Ratio
P/E ratio that is half the growth rate (or less)
Positive net cash position the past year and most recent quarter
Equity to debt ratio greater than 0.75 for past year and most recent quarter
Positive net income past year and 12 trailing months
Free cash flow ratio greater than 0 and less than 10

Small Cap List Algorithm Criteria for DXCM

Revenue growing by at least 20% average per year over the last 5 years
Market Capitalization under 2 billion
Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months
Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months
Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year

Dividend List Algorithm Criteria for DXCM

Declared an ex-dividend date
Forward annual dividend rate greater than 2
Positive net cash position the past year and most recent quarter
Equity to debt ratio greater than 0.75 for past year and most recent quarter
Current ratio most recent quarter greater than 2
Cash Flow per Share greater than Trailing Dividend Rate

Bonus Criteria for DXCM

P/E ratio less than five-year Average P/E ratio
Last Price to 52 Week Low Ratio Less Than 1
Total Cash Per Share > Last Day Price
P/S Ratio < 1
P/B Ratio < 1

Safety Rating Criteria for DXCM (50 out of 90)

Stock Price Rating (Max of 10) 9
Historical Stock Price Rating (Max of 10) 9
Stock Price Trend (Max of 10) 2
Book Value (Max of 10) 4
Book Value to Price (Max of 10) 0
Analyst Buy Ratings (Max of 5) 5
Analyst Strong Buy Ratings (Max of 5) 5
Dividend Yield Percentage (Max of 10) 0
Operating Margin (Max of 10) 4
Trading Volume (Max of 10) 10
Price to Earnings (Max of 10) 2

Latest News for for DXCM

Healthy Returns: Eli Lilly's cholesterol pill impresses in mid-stage trial 11/19/2024 9:04:00 PM
Medtronic ( MDT ) Q2 2025 Earnings Call Transcript 11/19/2024 8:15:00 PM
DexCom's Options Frenzy: What You Need to Know - DexCom ( NASDAQ:DXCM ) 11/18/2024 8:00:00 PM
Tiger Global Hedge Fund Buys Flutter Entertainment Stock, Sells DexCom - Flutter Entertainment ( NYSE:FLUT ) 11/14/2024 10:18:00 PM
1 Stock to Buy Near Its 52-Week Low and Hold for 10 Years 11/8/2024 3:15:00 PM
GoodRx ( GDRX ) Q3 2024 Earnings Call Transcript 11/8/2024 4:45:00 AM
Here's Why DexCom ( DXCM ) is a Strong Momentum Stock 10/28/2024 1:50:00 PM
Want Better Returns? Don?t Ignore These 2 Medical Stocks Set to Beat Earnings 10/28/2024 12:50:00 PM
ACHC FRAUD ALERT: BFA Law Notifies Acadia Healthcare Investors of Upcoming December 16 Court Deadline and Encourages You to Contact the Firm ( Nasdaq:ACHC ) - Acadia Healthcare Co ( NASDAQ:ACHC ) 10/27/2024 12:04:00 PM
Why DexCom Stock Flopped on Friday 10/25/2024 9:53:00 PM

Financial Details for DXCM

Company Overview

Ticker DXCM
Company Name Dexcom Inc
Country USA
Description DexCom, Inc. is a company that develops, manufactures, and distributes continuous glucose monitoring (CGM) systems for diabetes management. It operates internationally with headquarters in San Diego, California, and has a manufacturing facility in Mesa, Arizona.
Sector Name LIFE SCIENCES
Industry Name SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
Most Recent Quarter 9/30/2024
Next Earnings Date 2/6/2025

Stock Price History

Last Day Price 74.88
Price 4 Years Ago 92.43
Last Day Price Updated 11/20/2024 3:59:03 PM EST
Last Day Volume 3,074,861
Average Daily Volume 4,679,141
52-Week High 142.00
52-Week Low 62.34
Last Price to 52 Week Low 20.12%

Valuation Measures

Trailing PE 45.60
Industry PE 52.46
Sector PE 40.32
5-Year Average PE 107.34
Free Cash Flow Ratio 12.89
Industry Free Cash Flow Ratio 35.05
Sector Free Cash Flow Ratio 27.97
Current Ratio Most Recent Quarter 2.46
Total Cash Per Share 5.81
Book Value Per Share Most Recent Quarter 5.07
Price to Book Ratio 14.78
Industry Price to Book Ratio 5.44
Sector Price to Book Ratio 20.88
Price to Sales Ratio Twelve Trailing Months 7.43
Industry Price to Sales Ratio Twelve Trailing Months 13.48
Sector Price to Sales Ratio Twelve Trailing Months 7.11
Analyst Buy Ratings 15
Analyst Strong Buy Ratings 5

Share Statistics

Total Shares Outstanding 390,595,000
Market Capitalization 29,247,753,600
Institutional Ownership N/A

Dividends

Ex-Dividend Date N/A
Last Dividend Amount 0.00
Current Dividend Amount 0.00
Total Years Dividend Increasing N/A
Trailing Annual Dividend Rate 0.00
Trailing Annual Dividend Yield 0.41%
Forward Annual Dividend Rate 0.00
Forward Annual Dividend Yield 0.00%
5-Year Dividend Payments Count 0
3-Year Average Dividend Yield 0.00%
5-Year Average Dividend Yield 0.00%
1-Year Dividend Growth Rate Percentage 0.00%
3-Year Dividend Growth Rate Percentage 0.00%
5-Year Dividend Growth Rate Percentage 0.00%
All-Time Dividend Growth Rate Percentage 0.00%
Dividend Payout Ratio N/A

Income Statement

Quarterly Earnings Growth YOY 15.70%
Annual Earnings Growth 58.70%
Reported EPS 12 Trailing Months 1.65
Reported EPS Past Year 1.20
Reported EPS Prior Year 1.51
Net Income Twelve Trailing Months 680,800,000
Net Income Past Year 541,500,000
Net Income Prior Year 341,200,000
Quarterly Revenue Growth YOY 2.00%
5-Year Revenue Growth 28.03%
Operating Margin Twelve Trailing Months 0.15

Balance Sheet

Total Cash Most Recent Quarter 2,271,200,000
Total Cash Past Year 2,726,300,000
Total Cash Prior Year 2,452,300,000
Net Cash Position Most Recent Quarter -168,400,000
Net Cash Position Past Year 292,100,000
Long Term Debt Past Year 2,434,200,000
Long Term Debt Prior Year 1,970,300,000
Total Debt Most Recent Quarter 2,439,600,000
Equity to Debt Ratio Past Year 0.46
Equity to Debt Ratio Most Recent Quarter 0.45
Total Stockholder Equity Past Year 2,068,600,000
Total Stockholder Equity Prior Year 2,131,800,000
Total Stockholder Equity Most Recent Quarter 1,979,000,000

Free Cash Flow

Free Cash Flow Twelve Trailing Months 535,000,000
Free Cash Flow Per Share Twelve Trailing Months 1.37
Free Cash Flow Past Year 511,900,000
Free Cash Flow Prior Year 304,700,000

Options

Put/Call Ratio 0.30
Has Options Options Chain
Liquidity Rating

Technical Analysis

Yahoo Finance Chart Yahoo Finance Chart
MACD 0.89
MACD Signal 0.34
20-Day Bollinger Lower Band 49.18
20-Day Bollinger Middle Band 75.06
20-Day Bollinger Upper Band 100.95
Beta 1.17
RSI 63.90
50-Day SMA 105.71
150-Day SMA 104.99
200-Day SMA 107.99

System

Modified 11/20/2024 11:31:55 PM EST